Femasys Inc 8-K Filing

FAQ

Key Financial Figures

• $0.001 — ich registered Common Stock, par value $0.001 per share FEMY The Nasdaq Stock Mar
• $450,000 — g will receive an annual base salary of $450,000 and he will be eligible to participate

Filing Documents

• ef20069522_8k.htm (8-K) — 35KB
• ef20069522_ex10-1.htm (EX-10.1) — 127KB
• ef20069522_ex99-1.htm (EX-99.1) — 15KB
• image00002.jpg (GRAPHIC) — 3KB
• 0001140361-26-012538.txt ( ) — 349KB
• femy-20260330.xsd (EX-101.SCH) — 4KB
• femy-20260330_lab.xml (EX-101.LAB) — 22KB
• femy-20260330_pre.xml (EX-101.PRE) — 16KB
• ef20069522_8k_htm.xml (XML) — 4KB

02

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers (c) On April 1, 2026, Femasys Inc. (the "Company") announced the hiring and appointment of John Canning as its Chief Operating Officer, effective March 30, 2026. Mr. Canning, age 52, most recently served as Chief Operating Officer at Terumo Aortic from April 2017 to February 2026, where he led global operations and technology functions. Prior to that he held senior leadership roles at Bolton Medical from 2003 to 2017, including Chief Operating Officer and was instrumental in Terumo's acquisition of Bolton Medical. Earlier in his career, he held manufacturing operations leadership positions at Medtronic from 1999 to 2003. Mr. Canning holds a B.S. in Mechanical Engineering from College of New Jersey. The Company entered into an employment agreement (the "Employment Agreement") with Mr. Canning in connection with his appointment as Chief Operating Officer. Under the Employment Agreement, which is effective March 30, 2026, Mr. Canning will receive an annual base salary of $450,000 and he will be eligible to participate in the Company's annual bonus program, with a target bonus of 40% of his base salary. In addition, the Employment Agreement provides that, as a material inducement to Mr. Canning to enter into employment with the Company and, as approved by the Board of Directors, Mr. Canning will be granted a nonstatutory stock option to purchase 150,000 shares of the Company's Common Stock, $0.001 par value per share (the "Common Stock") on March 30, 2026, as an inducement grant outside of the Company's 2021 Equity Incentive Plan pursuant to Nasdaq Listing Rule 5635(c)(4) (the "Inducement Award"), with an exercise price per share equal to the closing price per share of the Common Stock on the Nasdaq Stock Market on the grant date. The Inducement Award will vest as to 25% of the shares underlying the stock opt

01

Item 8.01 Other Events On April 1, 2026, the Company issued a press release announcing the appointment of Mr. Canning as its Chief Operating Officer. A copy of the press release is being filed as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.

Financial Statements and Exhibits

Financial Statements and Exhibits. (d) Exhibits. Exhibit No. Description 10.1 Employment Agreement, dated as of March 30, 2026, between Femasys Inc. and John Canning 10.2 Form of Inducement Stock Option Agreement 99.1 Press Release of Femasys Inc. dated April 1, 2026

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Femasys Inc. By: /s/ Kathy Lee-Sepsick Names: Kathy Lee-Sepsick Title: Chief Executive Officer Date: April 1, 2026

View Full Filing

View this 8-K filing on SEC EDGAR